{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:14:18Z","timestamp":1789532058403,"version":"build-2803163510"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/mpa.0000000000000326","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T09:37:44Z","timestamp":1429177064000},"page":"859-867","source":"Crossref","is-referenced-by-count":22,"title":["Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post\u2013Endoscopic Retrograde Cholangiopancreatography Pancreatitis"],"prefix":"10.1097","volume":"44","author":[{"given":"Tarun","family":"Rustagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Njei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210212","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.giec.2014.09.006","article-title":"Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.","volume":"25","author":"Rustagi","year":"2015","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"R2-2-20210212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.giec.2014.09.005","article-title":"Endoscopic retrograde cholangiopancreatography-related adverse events: general overview.","volume":"25","author":"Rustagi","year":"2015","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"R3-2-20210212","first-page":"1561","article-title":"A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.","volume":"87","author":"Sternlieb","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"R4-2-20210212","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2006.10.030","article-title":"Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.","volume":"65","author":"Andriulli","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R5-2-20210212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mge.2003.307","article-title":"Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.","volume":"58","author":"Sherman","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"R6-2-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10620-008-0709-9","article-title":"Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis.","volume":"55","author":"Shao","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R7-2-20210212","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.","volume":"366","author":"Elmunzer","year":"2012","journal-title":"N Engl J Med"},{"key":"R8-2-20210212","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s00535-012-0554-7","article-title":"Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial.","volume":"47","author":"Otsuka","year":"2012","journal-title":"J Gastroenterol"},{"key":"R9-2-20210212","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.gie.2012.08.021","article-title":"Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.","volume":"76","author":"Ding","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"R10-2-20210212","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/MPA.0000000000000086","article-title":"The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.","volume":"43","author":"Ahmad","year":"2014","journal-title":"Pancreas"},{"key":"R11-2-20210212","first-page":"1632","article-title":"Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis.","volume":"57","author":"Zheng","year":"2008","journal-title":"Gut"},{"key":"R12-2-20210212","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1440-1746.2010.06465.x","article-title":"Hepato-biliary clinical trials and their inclusion in the Cochrane Hepato-Biliary Group register and reviews.","volume":"26","author":"Klingenberg","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R13-2-20210212","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic.","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"},{"key":"R14-2-20210212","first-page":"141","article-title":"Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach Korean J Intern Med.","volume":"28","author":"Cheon","year":"2013","journal-title":""},{"key":"R15-2-20210212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R17-2-20210212","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing Use and avoidance of continuity corrections in meta-analysis of sparse data.","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"key":"R18-2-20210212","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"R19-2-20210212","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1556\/OH.2012.29403","article-title":"Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis in Hungarian.","volume":"153","author":"Dobronte","year":"2012","journal-title":"Orv Hetil"},{"key":"R20-2-20210212","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MCG.0b013e3181eb600e","article-title":"A randomized controlled trial of valdecoxib and glyceryl trinitrate for the prevention of post-ERCP pancreatitis.","volume":"45","author":"Bhatia","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R21-2-20210212","doi-asserted-by":"crossref","first-page":"AB232","DOI":"10.1016\/j.gie.2010.03.477","article-title":"A prospective, multicenter, randomized, double blinded controlled study to determine whether a single dose of intraduodenal indomethacin can decrease the incidence and severity of post-ERCP pancreatitis.","volume":"71","author":"Elmi","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"R22-2-20210212","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3748\/wjg.15.3999","article-title":"Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis.","volume":"15","author":"Senol","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R24-2-20210212","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.gie.2007.04.012","article-title":"Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.","volume":"66","author":"Cheon","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R25-2-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1572-0241.2007.01165.x","article-title":"Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP.","volume":"102","author":"Sotoudehmanesh","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R26-2-20210212","first-page":"330","article-title":"Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes in Spanish.","volume":"99","author":"Montano Loza","year":"2007","journal-title":"Rev Esp Enferm Dig"},{"key":"R27-2-20210212","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0016-5085(03)00384-6","article-title":"Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.","volume":"124","author":"Murray","year":"2003","journal-title":"Gastroenterology"},{"key":"R28-2-20210212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1022399824880","article-title":"Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis.","volume":"22","author":"Folch","year":"1998","journal-title":"Inflammation"},{"key":"R29-2-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00534-004-0890-y","article-title":"A double-blind placebo-controlled trial of a leukotriene receptor antagonist in chronic pancreatitis in humans.","volume":"11","author":"Cartmell","year":"2004","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"R30-2-20210212","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/00365529709025068","article-title":"Peptide leukotriene receptor antagonist diminishes pancreatic edema formation in rats with cerulein-induced acute pancreatitis.","volume":"32","author":"Hirano","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R31-2-20210212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00042737-200404000-00003","article-title":"Leukotriene receptor antagonism in experimental acute pancreatitis in rats.","volume":"16","author":"Oruc","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R32-2-20210212","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/MPA.0b013e3181db2dfd","article-title":"Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats.","volume":"39","author":"Ozkan","year":"2010","journal-title":"Pancreas"},{"key":"R33-2-20210212","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/MPA.0b013e318214c8df","article-title":"Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats.","volume":"40","author":"Vigna","year":"2011","journal-title":"Pancreas"},{"key":"R34-2-20210212","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/00365528909090796","article-title":"Release of arachidonic acid metabolites during acute pancreatitis in pigs.","volume":"24","author":"Vollmar","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"R35-2-20210212","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/mge.2003.124","article-title":"Does a pancreatic duct stent prevent post-ERCP pancreatitis A prospective randomized study.","volume":"57","author":"Fazel","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"R36-2-20210212","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0016-5107(04)02013-9","article-title":"Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis A meta-analysis of controlled trials.","volume":"60","author":"Singh","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R37-2-20210212","first-page":"58","article-title":"Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications.","volume":"4","author":"Tarnasky","year":"2003","journal-title":"JOP"},{"key":"R38-2-20210212","first-page":"1977","article-title":"Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents Gastroenterology.","volume":"124","author":"Freeman","year":"2003","journal-title":""},{"key":"R39-2-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0016-5107(03)02530-6","article-title":"Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.","volume":"59","author":"Freeman","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"R41-2-20210212","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cgh.2012.12.043","article-title":"Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.","volume":"11","author":"Akbar","year":"2013","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0000000000000326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:36:59Z","timestamp":1620963419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201508000-00002"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0000000000000326","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}